DaVita Inc DVA

NYSE US Health Care

$240.09 ▲ +0.51% (+$1.23)

Index member: S&P 500

📅 Earnings This Week

Open $237.81

Prev Close $238.86

Day Range $236.09 – $240.91

52W Range $101.00 – $244.49

Market Cap $15.33B

P/E (TTM) 19.66

Beta 0.88

EPS (TTM) $10.77

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NEW YORK STOCK EXCHANGE, INC.
Currency	USD
IPO Date	1995-10-31
Shares Out.	64,200,000
Website	davita.com/ ↗
Phone	13105362668
Employees	78,000
Revenue	$3.27B
Gross Profit	$930.5M
Net Income	$275.0M
Free Cash Flow	$1.49B
Total Assets	$17.50B
Total Liabilities	$16.45B
Equity	-$476.3M

About DaVita Inc

DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.

DaVita Inc is a publicly traded company under the ticker symbol DVA on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.